News

NEW PODCAST | Precision Therapies – Reinventing Pharma Logistics

The Precision Therapy Logistics podcast episode dives into the logistics behind cutting-edge treatments like cell and gene and radioligand therapies, critical life-saving innovations that present unique logistical challenges. Tune in to learn what are the biggest logistical considerations of ATMPs (Advanced Therapy Medicinal Products).

Join Frank Van Gelder, Secretary General of Pharma.Aero, and his guests, Jade Verrept, Province of Antwerp and Cluster Manager of the University of Antwerp Science Park, Point of Contact for the Incubator Darwin and Co-Founder of ATLAS ATMP,  Mariyam Penate, Global Account Manager at Expeditors, and An D’Hondt, Senior External Manager at PwC, Project Expert in the Pharma.Aero Precision Therapy Logistics project.

Jade Verrept: “If you don’t factor logistics into your business model, you will not be able to reach patients. (…) We do advise early developers, we encourage them to think about the supply chain and allocate the necessary budgets to their logistics, even in the clinical trial phase. And of course, we also try to inform supply chain solution providers of the types of products that are coming their way and the way in which they can prepare for these new products. That’s part of the aim of at.las ATMP.”

Frank Van Gelder: “The model that we use today in big pharma is absolutely incompatible with the big wave that might come from these therapies.”

Mariyam Penate: “There is zero room for any sort of errors. What we’re looking to achieve here absolutely has to be fail-safe.”
“One of the key considerations that we should be looking at is to ensure that we are partnering early and partnering thoughtfully and making sure that we are bringing the partner into the supply chain with the developers and the scientists so that they can understand the high stakes and the weight of that social responsibility they have in regards to the product.”

An D’Hondt: “We will need to rethink logistics completely. (…) For these therapies, there is no such thing like a one-fits-all solution. Current logistic solutions for pharmaceuticals will not fit the purpose for these products. Precision therapies will require very different and highly controlled logistic services.”

Mariyam Penate: “We must throw the box out and not try and fit the solution within a box that exists today: throw the box away and make a brand-new solution.”

Additional resources:
  • Pharma.Aero Precision Therapy Logistics project
  • Precision Therapy Logistics Technical Report (available for Pharma.Aero only in the Member area of our website)
  • PTL Workshop Report (available for Pharma.Aero only in the Member area of our website)

Pharma.Aero’s podcast, Insights, was launched in 2023 as a powerful platform to further showcase valuable expertise and insights on topics relevant to life science logistics. Since its first episode, the podcast delved deep into the complexities of the life sciences and med tech supply chain, presenting a unique opportunity to explore challenges, issues, and innovative ideas that shape the industry.

Tune in on Spotify where all episodes are available.

 

Back to overview
My cart
Your cart is empty.

Looks like you haven't made a choice yet.

My cart
Your cart is empty.

Looks like you haven't made a choice yet.